The cloacinogenic plasmid DF13 (Clo DF13) originates from Enterobacter cloacae; however, Escherichia coli can serve as host as well, since biologically active Clo DF13-specific deoxyribonucleic acid, ribonucleic acid, and proteins are synthesized in E. coli (12, 25, 26) . The Clo DF13 plasmid directs the synthesis of an antibiotic protein, cloacin DF13, which inhibits the protein synthesis in sensitive strains by causing cleavage of a small fragment from the 3' end of the 16S ribonucleic acid of the 30S ribosomal subunit. This inactivation of ribosomes occurs both in vivo and in vitro (5) . Besides the synthesis of cloacin DF13, the Clo DF13 plasmid might be responsible for the synthesis of an immunity substance, because bacterial cells harboring this cloacinogenic plasmid are immune to the cloacin they produce. This immunity character seems to be specified by the plasmid itself, since bacterial cells that have lost their bacteriocinogenic plasmid are fully sensitive to the bacteriocin produced by the parent strain; furthermore, if a bacteriocinogenic plasmid is transferred to a sensitive strain, this strain will become immune within 15 min (8, 20) .
Previous efforts to study the nature of immunity of cloacinogenic cells by isolating immunity temperature-sensitive mutants have been unsuccessful (13) . Therefore, we have started to isolate the immunity substance from cloacinogenic E. coli minicells. The isolation and characterization of the colicin E3 immunity substance from Col E3-harboring cells have been described previously (10, 22) .
However, in those papers (10, 22) , no definite proof is presented that the purified immunity protein is a plasmid-specific protein. Therefore, we have isolated the immunity protein to cloacin DF13 from purified cloacinogenic minicells because all of the gene products that are synthesized de novo in these minicells are Clo DF13 plasmid specific (15) . It has been shown previously that in Clo DF13-harboring minicells the Clo DF13 plasmid codes for the synthesis of at least eight protein species; however, in the noninduced state, the Clo DF13 plasmid in minicells only directs the synthesis of three Clo DF13-specific proteins of molecular weights 70,000, 20,000, and 11,000 (14) . If the immunity substance is a Clo DF13 plasmidspecific protein, then it is obvious that one of these three proteins must be the Clo DF13 immunity protein, because even cloacinogenic cells that contain noninduced Clo DF13 plasmids are immune to cloacin DF13. 68 
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In this paper we describe the purification and characterization of a Clo DF13-specific protein from cloacinogenic minicells that inhibits the effects of cloacin DF13 on in vitro protein synthesis. In an accompanying paper (12), we describe experimental results indicating that the Clo DF13 immunity protein binds specifically with cloacin DF13 and thus protects the ribosomes from being inactivated by cloacin DF13.
MATERIALS AND METHODS Bacterial strains. The strains used in this study are listed in Table 1 . The nomenclature follows the proposals of Demerec et al. (7) . For a description of the min genotype of the minicell-producing strains, see reference 21 . A P678-54(Clo DF13-Rep3) strain was isolated in our laboratory after mutagenesis of strain P678-54(Clo DF13). The Clo DF13-Rep3 plasmid (previously referred to as Clo DF13-M3) is a Clo DF13 plasmid mutant; cells containing this mutant plasmid contain about 70 Clo DF13 plasmid copies per cell, whereas wild-type Clo DF13-harboring cells contain only 10 Clo DF13 copies per cell (16) . E. coli MRE 600 (deficient in ribonuclease I) was used for the preparation of S-30 extracts and S-100 supernatant factors (19) . Klebsiella edwardsii var. edwardsii S15 was used as indicator strain in the cloacin assay (24) .
Media and buffer solutions. The composition of brain heart infusion (BHI) medium, soft BHI agar, and supplemented mineral salts medium for the radioactive labeling of minicells has been described previously (13, 16 (14) .
Purification of minicells. A culture of strain P678-54(Clo DF13-Rep3) was grown in 1.6 liters of BHI medium at 37 C to a concentration of 2 x 109 cells per ml. Minicells were harvested by differential centrifugation and purified further by three successive sedimentations through 40-ml linear gradients of 5 to 20% sucrose as described by Kool et al. (15) . After the third sucrose gradient, the minicells were suspended in supplemented mineral salts medium at an A620 of 0.4. The yield of minicells was about 60 ml, and this purified minicell suspension usually contained less than 100 contaminating bacterial cells per 108 minicells.
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on November 3, 2017 by guest http://aac.asm.org/ Downloaded from CLO DF13-SPFCIFIC IMMUNITY PROTEIN: PURIFICATION Isolation of "4C-labeled Clo DF13 proteins. The purified minicell suspension (60 ml) was preincubated for 20 min at 37 C. '4C-labeled amino acids were then added to a final concentration of 5 MiCi/ml, and the incubation was continued for 90 min at 37 C. The minicells were collected by centrifugation at 27,000 x g for 7 min. The minicell pellet was lysed by the lysozyme-ethylenediaminetetraacetic acid-Brij 58 method as described by Clewel and Helinski (3). The minicell lysate was adjusted to 1 M KCl and stirred for 30 min at 0 C, and the mixture (5 ml) was centrifuged at 3,000 x g for 10 min. The pellet was extracted once more with 5 ml of 1 M KCl. The combined extracts contained more than 90% of the total radioactivity incorporated by these minicells into hot acid-insoluble material.
Growth of, induction of, and protein extraction from P678-54(Clo DF13-Rep3). An overnight culture of strain P678-54(Clo DF13-Rep3) was diluted 1:10 into 1.5 liters of BHI medium and grown at 37 C to an A.,20 of 0.5. Mitomycin C was added to a final concentration of 0.5 ,gg/ml, and growth was continued for 90 min. (Under these conditions about a 40-fold increase of cloacin synthesis occurs; the cells do not lyse probably because in vivo E. coli is not sensitive to cloacin DF13.) The cells were harvested by centrifugation at 3,000 x g for 10 min and washed twice with saline. The cell pellet was suspended in 10 ml of 1 M KCl in buffer A and lysed by repeated freezing and thawing (three times). The lysate was then stirred for 20 min at 0 C. The cell debris was removed by centrifugation at 23,000 x g for 20 min and extraction was repeated once more. The combined extracts were stored in liquid nitrogen or used immediately for further purification.
Protein determination. The protein concentration of the purified immunity protein and cloacin DF13 preparations was determined by the method of Lowry et al. (17) . Bovine serum albumin (Serva, 11920) was used as protein standard.
Polyacrylamide gel electrophoresis. Discontinuous sodium dodecyl sulfate-polyacrylamide gels were prepared by the method of Spear and Roizman (24) . Autoradiography. The positions of "C-labeled proteins in polyacrylamide gels were detected by the autoradiography method as described by Bonner and Laskey (2) . After staining and destaining, the gels were dehydrated in dimethyl sulfoxide, immersed in four times their volume of 20% (wt/vol) 2,5-diphenyloxazole in dimethyl sulfoxide (22.2%, wt/wt) for 3 h, and finally washed in 20 volumes of water for 1 h. After this procedure, the gels were sliced longitudinally and dried as described previously (14) . The dried gels were exposed to Kodak X-ray film (type XP Royal "X-omat") for several days at -20 C, depending on the amount of 14C radioactivity present in the gels. The molecular weight of the "4C-labeled immunity protein was estimated from the plot of relative migration distance in sodium dodecyl sulfate-gels of six marker proteins (serum albumin, catalase, aldolase, chymotrypsinogen, myoglobin, and cytochrome c) against their molecular weights (28).
RESULTS
Isolation and purification of the Clo DF13 immunity protein from minicells and induced cells. We have isolated the immunity substance from purified Clo DF13-harboring minicells because we wanted to prove that the immunity substance is a Clo DF13 plasmid-specific protein and because it is rather easy to isolate Clo DF13-specific proteins from Clo DF13-harboring minicells. Data obtained from preliminary experiments showed that from Clo DF13-harboring minicells a Clo DF13-specific protein can be extracted that inhibits the in vitro effects of cloacin DF13. The amount of immunity protein that can be extracted from cloacinogenic minicells is too small for a sufficient number of experiments. To increase the amount of immunity protein, we added a lysate of cloacinogenic parental cells to the Clo DF13 plasmid proteins extracted from cloacinogenic minicells. It is obvious that immunity protein can be extracted even from noninduced cloacinogenic cultures, because every cloacinogenic cell, whether induced or not, is immune to cloacin DF13. However, the data in Fig. 1 show that the amount of immunity protein extracted from mitomycin C-induced cells was slightly higher (about three times) as compared with noninduced cloacinogenic cells. Therefore, throughout this study, we added lysates of mitomycin C-induced cloacinogenic cells to the minicell lysates for the isolation of the Clo DF13 immunity protein.
The "4C-labeled extract (usually 9.106 dpm of hot acid-insoluble material) from purified cloacinogenic minicells previously incubated with "4C-labeled amino acids was mixed with the extract from 1.5 liters of mitomycin C-induced P678-54(Clo DF13-Rep3) cells and dialyzed in dialyzer tubing (molecular weight cutoff: 3,500) against buffer A. After overnight dialysis, the mixture (total volume of 15 ml) was applied to a DEAE-Sephadex A-50 column (2. previously equilibrated with buffe were eluted with a 150-ml linear gi to 1.0 M KCl in buffer A, followec step wash with 2 M KCl in buffer (4 ml each) were collected at a fl ml/h. Samples (100 ,ul) of each i taken to measure the amount of insoluble in hot acid and determ tions of the "4C-labeled Clo DFL typical elution profile of the DE} shown in Fig. 2 . The "4C-labeled I were pooled and assayed for in DF13 activity by spot tests on s and for immunity protein acti% DF13 eluted in the void volume o and was completely separated fro] nity activity, which bound rather DEAE-Sephadex, implying tha acidic protein (Fig. 2) .
Fractions collected at a flow rate of 5.5 ml/h. Small volumes (50 ul) were taken to determine the amount of radioactive material in each fraction. The resulting profile is presented in Fig. 3 . After dialysis against TMN buffer, fractions were assayed for immunity activity in 150-,ul in vitro systems containing 2 ,ug of cloacin DF13.
Those fractions, which gave complete protec-05 S tion against the action of 2 ,ug of cloacin DF13 on in vitro protein synthesis, were pooled and ein present in tested for purity by discontinuous sodium do-,cin C-induced decyl sulfate-polyacrylamide gel electrophore-KCI extracts, sis. At this stage of the purification procedure, Sephadex A-50 the radioactivity runs as a single band on this with 40 ml of gel, implying that the "4C-labeled protein is the Proteins were only labeled protein that is present in this r2creasing KCI preparation (see Fig. 5 ). However, a duplicate 4). Fractions gel (see Fig. 5A ), which was stained with Cooe pooled and massie brilliant blue, revealed the presence itive amount of of about 12 minor, contaminating proteins, KCI extracts" most probably host proteins. Therefore, anf these extracts other chromatographic step was needed for otein synthesis complete purification. Portions (6 ml) of the re expressed as pooled immunity activity-containing fractions ycin C-induced from the Sephadex G-75 column were dialyzed )m noninduced overnight against buffer A. The dialyzed solution was applied to a DEAE-Sephadex A-50 column (0.9 by 10 cm) previously equilibrated r A. Proteins with buffer A. Proteins were eluted with 30-ml radient of 0.0 step washes with increasing KCl concentra-I by a 100-ml tions in buffer A. Fractions (1 ml) were col-A. Fractions lected at a flow rate of 12 ml/h. Fractions were ow rate of 46 assayed for radioactivity and immunity activity. fraction were The data (Fig. 4) show that only the radioacradioactivity tive fractions contain immunity activity. These mine the posi-fractions were pooled, dialyzed against TMN 3 proteins. A buffer, and assayed for purity by gel electrokE column is phoresis. Figure 5 shows that the pooled improtein peaks munity protein fractions were pure according vivo cloacin to the urea-polyacrylamide gels (Fig. 5E, F) and -ensitive cells the sodium dodecyl sulfate-polyacrylamide gels vity. Cloacin (Fig. 5C, D the purified "anti-cloacin" activity nevertheless interacted specifically with cloacin DF13 and, consequently, that this Clo DF13 immunity protein was not able to prevent the inhibition of in vitro protein synthesis caused by colicin E3. The results of these experiments (Table 2) showed that at least 20 times more Clo DF13 immunity protein is required to inactivate a given amount of colicin E3 compared with cloacin DF13. We concluded, therefore, that the Clo DF13 immunity protein interacts only very weakly with colicin E3.
This weak interaction, however, might imply that Clo DF13-harboring cells are immune not only to homologous cloacin DF13, but also, to a certain extent, to colicin E3. Therefore, we spotted 5 ul of appropriate dilutions of colicin E3 on BHI agar plates covered with a layer of cloacinogenic and non-cloacinogenic cells suspended in soft BHI agar. The results of these experiments (Table 3) showed that cells cloacinogenic for Clo DF13 showed immunity to a small amount of colicin E3. Cells containing the Clo DF13-Rep3 mutant plasmid showed immunity to about an eightfold higher amount of colicin E3. This is most likely due to the fact that these mutant cloacinogenic cells contain about seven times more Clo DF13 plasmid copies per cell compared with wild-type cloacinogenic cells. As the result of this increased gene dosage, about a sevenfold increase in immunity protein will most probably occur, because in Clo DF13-Rep3-harboring minicells about a sevenfold increase in proteins synthesized by the nonrepressed part of the Clo DF13 plasmid is observed (16) .
In Table 3 , a slight difference between strain P678-54(Clo DF13-Rep3) and TS214(Clo DF13-Rep3) can be observed. If 8 killing units of colicin E3 is added, the amount of immunity protein present in P678-54(Clo DF13-Rep3) cells is probably not sufficient to neutralize every adsorbed colicin molecule, resulting in the observed turbid halos. Strain TS214(CloDF13-Rep3) might contain fewer receptor sites for colicin molecules, or the amount of immunity protein in these cells could be slightly higher compared with P678-54(Clo DF13-Rep3) cells, resulting in the observed higher immunity to colicin E3. Since the in vitro as well as the in vivo experiments show that the Clo DF13 immunity protein interacts only weakly with colicin E3, we concluded that the purified Clo DF13 immunity protein interacts rather specifically with cloacin DF13.
DISCUSSION
In this paper we show that a "4C-labeled Clo DF13 plasmid-specific protein isolated from Clo DF13 minicells copurifies with the "anticloacin" activity isolated from Clo DF13 cells. This purified immunity protein preparation is able to prevent the inhibitory action of cloacin DF13 on in vitro protein synthesis. In the accompanying paper (12), we show that the congruence of the "4C-labeled Clo DF13 plasmid-specific protein (from minicells) and immunity protein (from cells) is maintained under a variety of physical conditions and that the properties of this Clo DF13 plasmid-specific protein are identical to those of the immunity protein. Therefore, we conclude that the Clo DF13 immunity protein is de novo synthesized in Clo DF13-harboring minicells, implying that the Clo DF13 immunity protein is a Clo DF13 plasmid-coded protein. (When this paper was submitted, Sidikaro and Nomura [23] reported that the Col E3 immunity protein is synthesized in a Col E3 deoxyribonucleic acid-containing in vitro system, implying that it is a Col E3 plasmid-specific protein.) It turned out that this protein, which has a molecular weight of about 10,000, is one of the three polypeptides synthesized by the noninduced Clo DF13 plasmid in minicells (14) .This implys that the gene responsible for the synthesis of the Clo DF13 immunity protein is located on a region of the Clo DF13 plasmid deoxyribonucleic acid that is not repressed under the usual conditions. These results agree with in vivo data which show that noninduced cloacinogenic cells are immune against homologous cloacin and that immunity protein can be isolated from such noninduced cloacinogenic cells. The gene that codes for the synthesis of cloacin DF13 is most probably located on an at least partially repressed part of the Clo DF13 plasmid since cloacin DF13 synthesis is strongly increased after induction with mitomycin C. From these results, it is obvious that the genes that code for immunity protein and cloacin DF13 are not located in the same regulatory unit.
This conclusion is confirmed by induction experiments with mitomycin C, which show that cloacin DF13 synthesis is increased about 40-fold, whereas the synthesis of Clo DF13 immunity protein is only slightly increased. These results imply that an excess of immunity protein is synthesized under noninduced conditions, since the amount of immunity protein is even sufficient to neutralize the strongly increased amount of cloacin DF13 synthesized in Strains---- b Killing units per 5 Ml.
vivo upon induction with mitomycin C. These data disagree with the observations of Jakes et al. (10) , who show that about 50 to 100 times more colicin E3 immunity protein can be extracted from mitomycin C-induced cells. However, they measured only the amount of free immunity protein present outside the cell envelope, whereas our isolation procedure (legend to Fig. 1 ) covers the total amount of free as well as cloacin-bound immunity protein present inside and outside the cell envelope.
The data obtained from the DEAE chromatography showed that the immunity protein was bound rather tightly to the column, implying that the immunity protein is an acidic protein.
Additional evidence for this acidic character was obtained from the gel electrophoresis at pH 8.4. Recent data from our laboratory (4) showed that the Clo DF13 immunity protein isolated from cloacinogenic cells has an isoelectric point of 4.30. Furthermore, we have shown in this paper that the inactivation of cloacin DF13 by the Clo DF13 immunity protein is rather specific because the Clo DF13 immunity interacted only very weakly with a closely related bacteriocin, colicin E3.
In the accompanying paper we present data that prove that the immunity protein binds directly to cloacin DF13 both in vivo and in vitro and that the formed cloacin-immunity protein complex is no longer able to cause inactivation of ribosomes in vitro. Therefore, we believe that this purified Clo DF13 plasmidspecific immunity protein is responsible for the observed immunity of cloacinogenic cells to homologous cloacin DF13.
